Indian Army

Punjab | Amritsar
  • Download
Time left to bid

11

Days

2

Hours

9

Minutes
Timeline

Tender Roadmap

Publish Date
23 Jul 2025

Tender is published for seller Participation.

Bid Submission End Date
07 Aug 2025

Last day to participate Tender on Gem platform.

Evaluation Date
07 Aug 2025

Technical committe will evaluate Bid and Open Results.

Earnest Amount
Refer Doc
Tender Amount
0.03 Cr
Department
Department Of Military Affairs
Item Category
Ubidecarenone 300mg Tab Rivastigmine 1.5mg Cap Verapamil 120mg Sr Tab Tiotropium 18mcg Rotacap Risperidone 0.5 mg Tab Zolpidem 5 mg Tab Prucalopride 1 mg Tab Spironolactone 50 mg Tab Torsemide10 mg plus Spironolactone 50 mg Tab
Purchaser Address
AMRITSAR CITY
Work Description

ubidecarenone 300 mg Tab;99840;Ubidecarenone 300mg Tab Rivastigmine 1.5mg Cap Verapamil 120mg Sr Tab Tiotropium 18mcg Rotacap Risperidone 0.5 mg Tab Zolpidem 5 mg Tab Prucalopride 1 mg Tab Spironolactone 50 mg Tab Torsemide10 mg plus Spironolactone 50 mg Tab

Quantity 99840
Bid Type BOQ
Website https://bidplus.gem.gov.in
Eligibility
Minimum Average Annual Turnover of the bidder For 3 Years 1 Lakh s
OEM Average Turnover Last 3 years 2 Lakh s
Years of Past Experience Required for same similar service 3 Year s
Past Experience of Similar Services required N/A
MSE Exemption No
Startup Exemption for Years Of Experience No
Document Required from Reseller Experience Criteria Past Performance Bidder Turnover Certificate Requested in ATC OEM Authorization Certificate OEM Annual Turnover Compliance of BoQ specification and supporting document In case any bidder is seeking exemption from Experience Turnover Criteria the supporting documents to prove his eligibility for exemption must be uploaded for evaluation by the buyer
Bid to RA Enabled No
Evaluation Method Item wise evaluation
Advisory Bank N/A
MSE Purchase Preference Yes
Reserved for MSE N/A
Reserved for MII N/A
MII Compliance/MII Purchase Preference No
My Evaluation Notes
Add notes

We use cookies to improve your browsing experience. By continuing to use this website, you consent to the use of cookies.